Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study
Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study have?
Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study has 482 citations in the OpenAlex counts ScholarIQ stores.
When was Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study published?
Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study has 2004 year in the ScholarIQ index.
What is the open-access status of Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study?
Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study has bronze oa status in the ScholarIQ index.
What is the DOI of Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study?
The DOI for Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study is on the source record.
What is the PMID of Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study?
The PMID for Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study is on the source record.
What is the OpenAlex record for Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study?
The OpenAlex for Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study is on the source record.